Head-To-Head Contrast: Hims & Hers Health (NYSE:HIMS) versus Labcorp (NYSE:LH)

Labcorp (NYSE:LH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Earnings & Valuation

This table compares Labcorp and Hims & Hers Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95 billion	2.10	$876.50 million	$12.19	29.69
Hims & Hers Health	$2.58 billion	2.50	$128.37 million	($0.63)	-43.79

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Labcorp and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Labcorp	6.88%	17.13%	7.96%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Labcorp and Hims & Hers Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0	3	7	1	2.82
Hims & Hers Health	1	11	3	0	2.13

Labcorp presently has a consensus target price of $365.67, indicating a potential upside of 1.02%. Hims & Hers Health has a consensus target price of $32.43, indicating a potential upside of 17.55%. Given Hims & Hers Health’s higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Labcorp.

Institutional and Insider Ownership

95.9% of Labcorp shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 0.8% of Labcorp shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Labcorp has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.44, meaning that its stock price is 144% more volatile than the S&P 500.

Summary

Labcorp beats Hims & Hers Health on 11 of the 15 factors compared between the two stocks.

About Labcorp

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.